Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
Sekino Y, Takemoto K, Murata D, Babasaki T, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Taniyama D, Shigeta M, Kuraoka K, Mita K, Kaneko M, Sentani K, Oue N, Teishima J. Sekino Y, et al. Among authors: takemoto k. Anticancer Res. 2021 Oct;41(10):4875-4883. doi: 10.21873/anticanres.15301. Anticancer Res. 2021. PMID: 34593435
Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment.
Goto K, Honda Y, Ikeda K, Takemoto K, Higaki T, Hayashi T, Kobatake K, Nakamura Y, Sekino Y, Inoue S, Awai K, Yasui W, Teishima J. Goto K, et al. Among authors: takemoto k. Sci Rep. 2021 Jul 9;11(1):14251. doi: 10.1038/s41598-021-93414-2. Sci Rep. 2021. PMID: 34244567 Free PMC article.
P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
Sekino Y, Takemoto K, Murata D, Babasaki T, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Taniyama D, Shigeta M, Kuraoka K, Mita K, Kaneko M, Sentani K, Oue N, Teishima J. Sekino Y, et al. Among authors: takemoto k. Anticancer Res. 2021 Sep;41(9):4287-4294. doi: 10.21873/anticanres.15233. Anticancer Res. 2021. PMID: 34475048
DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis.
Kobatake K, Ikeda K, Nakata Y, Yamasaki N, Kanai A, Sekino Y, Takemoto K, Fukushima T, Babasaki T, Kitano H, Goto K, Hayashi T, Sentani K, Teishima J, Kaminuima O, Hinata N. Kobatake K, et al. Among authors: takemoto k. Urol Oncol. 2022 Oct;40(10):456.e9-456.e18. doi: 10.1016/j.urolonc.2022.07.001. Epub 2022 Jul 30. Urol Oncol. 2022. PMID: 35918249
Evaluation of urinary catheters for effective manual bladder washout.
Kobatake K, Inoue S, Takemoto K, Fukushima T, Sekino Y, Ikeda K, Goto K, Hayashi T, Teishima J, Hinata N. Kobatake K, et al. Among authors: takemoto k. Sci Rep. 2022 Aug 23;12(1):14359. doi: 10.1038/s41598-022-18778-5. Sci Rep. 2022. PMID: 35999265 Free PMC article.
799 results